Media coverage
1
Media coverage
Title Biohaven Enrolls First Patient in Phase 3 Generalized Anxiety Disorder Trial of Troriluzole Media name/outlet Pharmacy Choice Country/Territory United States Date 21/02/19 URL www.pharmacychoice.com/news/article.cfm?Article_ID=2193261 Persons Sanjay Mathew